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Abstract
Background: We sought to determine if nasopharyngeal (NP) cultures taken at times of healthy visits or at onset of
acute otitis media (AOM) could predict the otopathogen mix and antibiotic-susceptibility of middle ear isolates as
determined by middle ear fluid (MEF) cultures obtained by tympanocentesis.
Methods: During a 7-year-prospective study of 619 children from Jun 2006-Aug 2013, NP cultures were obtained
from 6-30 month olds at healthy visits and NP and MEF (by tympanocentesis) at onset of AOM episodes.
Results: 2601 NP and 530 MEF samples were collected. During healthy visits, S. pneumoniae (Spn) was isolated from
656 (31.7%) NP cultures compared to 253 (12.2%) for Nontypeable Haemophilus influenzae (NTHi) and 723 (34.9%)
for Moraxella catarrhalis (Mcat). At onset of AOM 256 (48.3%) of 530 NP samples were culture positive for Spn, 223
(42%) for NTHi and 251 (47.4%) for Mcat, alone or in combinations. At 530 AOM visits, Spn was isolated from 152
(28.7%) of MEF compared to 196 (37.0%) for NTHi and 104 (19.6%) for Mcat. NP cultures collected at onset of AOM
but not when children were healthy had predictive value for epidemiologic antibiotic susceptibility pattern
assessments.
Conclusions: NP cultures at onset of AOM more closely correlate with otopathogen mix than NP cultures at healthy
visits using MEF culture as the gold standard, but the correlation was too low to allow NP cultures to be recommended
as a substitute for MEF culture. For epidemiology purposes, antibiotic susceptibility of MEF isolates can be predicted by
NP culture results when samples are collected at onset of AOM.
Keywords: Acute otitis media, Tympanocentesis, Streptococcus pneumoniae, Haemophilus influenzae (non-typeable),
Moraxella catarrhalis
Background
Acute otitis media (AOM) is one of the most common dis-
eases in childhood and causes a considerable illness burden
for children. Streptococcus pneumoniae (Spn), Nontypeable
Haemophilus influenzae (NTHi) and Moraxella catarrhalis
(Mcat) are the 3 main pathogens causing AOM [1,2]. The
“gold-standard” for etiologic diagnosis of AOM is by de-
tecting pathogens in middle ear fluid (MEF) by culture
[1,2]. However tympanocentesis is not routinely performed
to obtain and culture MEF, so scientists and clinicians
are in a conundrum regarding scant data to allow
recommendations for treatment of AOM or sinusitis,
leading to the suggestion that there may be no choice
but to rely on nasopharyngeal cultures (NP) [3].
NP cultures have been used in the past as an epidemio-
logic tool to monitor the mix of otopathogens circulating
in a country or region, and their antibiotic susceptibility
pattern [4]. However, in a recent systematic review van
Dongen et al [5] found that concordances between NP
samples collected at onset of AOM compared to MEF iso-
lates vary from 68% to 97% per microorganism. For the
most prevalent microbes, positive predictive values were
about 50%. Most negative predictive values were moderate
to high, with a range from 68% up to 97%. The results in-
dicate that NP samples do not provide an accurate proxy
for those of middle ear fluid.
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In 2006, we began a longitudinal, multi-year, prospect-
ive study of AOM with a primary objective to further
understand the immunologic mechanisms responsible
for the otitis prone children. During the course of our
studies, we collected NP samples and MEF from these
children. We have periodically reported one microbio-
logic aspects of our research [6-15]. Here we sought to
answer several questions regarding the value of NP cul-
tures as to their concordance with MEF cultures collected
by tympanocentesis. Can NP samples taken during healthy
visits serve as a surrogate for MEF cultures? In the current
pneumococcal conjugate vaccine era, where otopathogen
mix has changed due to vaccine efficacy, are NP cultures
taken at onset of AOM concordant with MEF cultures?
Can antibiotic susceptibility of otopathogens collected
from the MEF be predicted by otopathogen isolates ob-
tained from the NP at healthy or at onset of AOM visits?
Methods
Study population
The details of the study design have been previously de-
scribed [16]. Study participants were recruited mainly
from a single private pediatric office (Legacy Pediatrics)
in Rochester, NY. Four other private pediatric groups
joined in the recruitment effort by referral of patients to
Legacy Pediatrics. Written informed parental consent
was obtained prior to any study procedures. This study
was approved by the University of Rochester IRB and
subsequently by the Rochester General Hospital IRB.
Eligibility
Children were enrolled into the study at the age of
6 months and prospectively followed until 30-36 months
of age (recently extended to 60 months of age). Inclusion
criteria were: healthy, full term birth, no craniofacial
anomalies and no known immune deficits. Participants
were required to receive all doses of Pneumococcal Con-
jugate Vaccine (PCV) according to the U.S. schedule; ei-
ther PCV7 or PCV13 depending on the date of their
enrollment. This is an ongoing prospective study where
not all the children have completed the planned visits.
In addition, although we request collecting samples at 6,
9, 12, 15, 18, 24 and at 30-36 months of age, most par-
ents don’t consent for all the seven collection visits, es-
pecially since a venipuncture occurs simultaneously with
the NP samplings. There is no statistically definable pat-
tern of missing data [16].
Sampling
Nasal wash (NW) and nasopharyngeal swab (NP) sam-
ples were collected over 7 years (June 2006 to August
2013), prospectively from healthy children at 6, 9, 12, 15,
18, 24 and 30-36 months of age. During visits with
AOM, MEF was obtained and cultured (both or a single
tympanocentesis procedure depending on whether the
infection was bilateral or unilateral) along with NW and
NP swabs. Diagnosis of AOM was performed by vali-
dated otoscopists when children with acute onset of
symptoms consistent with AOM had tympanic mem-
branes (TMs) that were: (1) bulging or full, and (2) a
cloudy or purulent effusion was observed, or the TM
was completely opacified, and (3) TM mobility was re-
duced or absent. Sampling procedures, microbiology
processing and identification, and molecular testing for
organism identification have been previously described
[6,8,15]. The oxacillin sensitivity of S. pneumoniae isolates
was determined using Taxo™ P Discs (Beckton, Dickinson).
Most Spn were also tested for their penicillin antibiotic
susceptibility along with other antibiotics using VITEK 2
Gram Positive Susceptibility Card-AST-GP68 (BioMerieux,
Inc) with the VITEK2 systems as described previously [17].
Microbiology data gathered from NW and NP are collect-
ively represented as NP culture results. The detection rate
of otopathogens from NW is higher than NP samples as
shown recently by our group [18].
Statistical analysis
All statistical analyses were conducted using GraphPad
Prism. Positive cultures for Spn, NTHi or Mcat from a
MEF samples were defined as the gold standard for the
etiologic diagnosis of AOM. In this analysis, 2 MEF sam-
ples obtained at the same visit were regarded as one case
of AOM and any otopathogen found in either or both of
these samples was treated as a single finding in that case.
The NW and NP swab results (hereafter referred to as
NP cultures) and MEF culture results were compared
with χ2 test. The positive predictive value (PPV) repre-
sents the proportion of NP samples that tested positive
for a NTHi or Spn or Mcat, for which the paired MEF
sample was also positive. The negative predictive value
(NPV) represents the proportion of NP samples that
tested negative for a common otopathogens, for which
the paired MEF sample was also negative. The sensitivity
represents the proportion of MEF samples that tested
positive for NTHi or Spn or Mcat, for which the paired
NP sample was also positive. The specificity represents
the proportion of MEF samples that tested negative for
NTHi or Spn or Mcat, for which the paired NP sample
was also negative. Bacterial otopathogens between healthy
vs AOM visits were compared using logistic regression
with bacterial presence as binary outcome and visit type
factor variable as predictor. A subject level random ef-
fect was included to model within-subject correlation.
The function glmer() from the R package lme4 was
used to calculate the model [19]. Estimates of the bac-
terial otopathogen presence rate and the visit group
odds ratio were calculated directly from the model. The
effects of age on the pathogens distribution during
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During the 7-years involved in the current report 619
children were enrolled in the study. There were 2071
healthy visits among the children. The distribution of
sample visits at 6, 9, 12, 15, 18, 24 and 30-36 months
was as follows: 402 (19.4%), 388 (18.7%), 366 (17.7%),
297 (14.3%), 292 (14.1%), 244 (11.8%) and 82 (4%) re-
spectively. A total of 530 AOM visits occurred in 309
children. The mean age of children at the time of AOM
episode was 13.7 months and median age was 12.
Comparison of otopathogen mix during NP colonization
at healthy and AOM visits
During healthy visits, Spn was isolated from 656 (31.7%)
NP cultures compared to 253 (12.2%) for NTHi and 723
(34.9%) for Mcat alone or in combination (Table 1). At
the onset of AOM, 256 (48.3%) of 530 NP samples were
culture positive for Spn, 223 (42%) for NTHi and 251
(47.4%) for Mcat, alone or in combinations (Table 1).
There was a significant difference (p < 0.0001) between
healthy and at onset of AOM NP cultures. Data show that
NTHi is more prevalent at AOM visits (Odd Ratio = 2.72).
Co-colonization with multiple otopathogens distribution
among healthy vs AOM visits are also shown in Table 1.
The ratio of frequency of NTHi (AOM/healthy) is about
200% and this estimate does not depend on the co-
pathogens. On the other hand, the ratio of frequency
(AOM/healthy) of Mcat alone or Spn alone are about
50-60% (ie. less prevalent in AOM visits). For Spn-Mcat
[no NTHi] the ratio of frequency (AOM/healthy) is
about 100%, ie. equally prevalent. When Mcat or Spn is
co-colonized with NTHi, there is an NTHi ratio of fre-
quency of about 200% indicating NTHi seems to domin-
ate. Otopathogens patterns change during the transition
to AOM. For example, a Mcat-alone colonization is
more likely to co-colonize during the transition to
AOM than NTHi-alone colonization would be. This
would explain the under-representation of Mcat-alone
colonizations among AOM visits, without having to as-
sume that Mcat-alone has a smaller transition rate to
AOM. Co-colonization with multiple otopathogens was
significantly higher (p < 0.0001) during AOM compared
to healthy visits (Table 1). Staphylococcus aureus was
also detected in 189 (9.1%) cases during healthy visits
and 34 (6.4%) cases during AOM visits.
Correlation of MEF otopathogens during AOM with NP
otopathogens isolated at healthy visits occurring within
one month before AOM
In order to determine whether the presence of bacteria
in NP samples obtained at healthy visits shortly prior to
onset of AOM might be predictive of the etiology of
AOM, we compared data from 81 AOM cases where NP
samples were taken within one month before an AOM
but not at onset of AOM. 31 (42%) of healthy NP colo-
nized children had the same pathogen in the MEF dur-
ing their AOM visit as they had at the healthy visit. We
analyzed the correlation between concordance of MEF
culture results and NP cultures taken at healthy visits 4,
3, 2, and 1 week prior to AOM onset. NP cultures taken
1 week prior to onset of AOM were more frequently
concordant with MEF cultures compared to NP cultures
taken 2 weeks prior to onset of AOM. As the time inter-
val between NP culture sampling and onset of AOM
lengthened the concordance became significantly lower
(p < 0.05).
Correlation of MEF otopathogens with the NP at onset of
AOM
To determine whether NP cultures correlated with MEF
cultures at onset of AOM, 519 AOM cases out of 530
cases were compared. In 165 (31.8%) cases there was an
Table 1 Comparison of NP Colonization at Healthy and AOM Visits along with MEF isolates during AOM
Isolates Healthy NP colonization AOM NP colonization AOM MEF
Number (%) Number (%) Number (%)
S. pneumoniae 292 (14.1) 70 (13.2) 110 (20.8)
Nontypeable H. influenzae 97 (4.7) 97 (18.2) 166 (31.3)
M. catarrhalis 382 (18.4) 78 (14.7) 71 (13.4)
NTHi + S. pneumoniae 60 (2.9) 52 (9.8) 19 (3.6)
M. catarrhalis + S. pneumoniae 245 (11.8) 99 (18.6) 22 (4.2)
NTHi +M. catarrhalis 37 (1.8) 39 (7.3) 10 (1.9)
NTHi +M. catarrhalis + S. pneumoniae 59 (2.8) 35 (6.6) 1 (0.2)
Other bacteriaǂ 870 (41.9) 35 (6.6) 44 (8.3)
No Bacteria 36 (1.7) 27 (5.1) 87 (16.4)
ǂOther bacteria were only sought when canonical otopathogens (S. pneumoniae, NTHi and M. catarrhalis) were not detected in the visits. They may have been
present along with main otopathogens but were not included in the calculations.
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exact match of MEF and NP isolate. In 359 (69.2%) cases
at least one otopathogen in the NP sample matched the
MEF culture result. In 160 (30.8%) cases no match was
observed between the NP and MEF.
The otopathogens in the MEF where exact matches
were observed in the NP (N = 165) is shown in Table 2.
The best correlation was observed for NTHi (~37%). In
194 (37.3%) children there was partial agreement be-
tween the NP and MEF with 1 organism from the MEF
found among 2 or 3 other otopathogens isolated from
the NP. The predictive value of NP cultures according to
otopathogen(s) in MEF is shown in Table 3.
Comparison of otopathogens with age
The presence of Spn, NTHi andMcat in the NP (Figure 1A)
and their presence in MEF during AOM (Figure 1B) were
compared according to the age of the child. During healthy
visits NP colonization by potential otopathogens sig-
nificantly increased with age (p <0.05, with correlation
r2 = 0.7880 for Spn, 0.931 for NTHi and 0.729 for
Mcat). During AOM, the otopathogens in the MEF be-
tween 6-24 months of age did not show any age specific
distribution. A negative trend with age was observed for
Spn (p = 0.06 and r2 = 0.617) but NTHi and Mcat were
uniformly distributed between 6-24 months of age.
Antibiotic susceptibility of NP isolates at AOM compared
to NP isolates at healthy visits
Recovery of Spn in the NP during healthy visits was not
significantly different from recovery the NP during AOM
visits. However, among NP cultures at healthy visits 187
(28.5%) of 656 Spn isolates were oxacillin resistant com-
pared to 98 (38.3%) of 256 of NP cultures at onset of
AOM (p = 0.004). The number of Spn detected during NP
colonization with a MIC ≥2 μg/ml to penicillin at healthy
visits was significantly lower 34 (6.7%) of 509 isolates
compared to 205 Spn isolates at AOM visits (12.7%). Re-
covery of NTHi in the NP during healthy visits was signifi-
cantly lower from the NP at onset of AOM (p < 0.0001).
During healthy visits 57 (22.5%) of the 253 NTHi iso-
lates were β-lactamase positive compared to 72(32.3%)
at onset of AOM (p = 0.016). The frequency of recovery
of Mcat in the NP during healthy visits was not signifi-
cantly different from recovery in the NP during AOM
visits and in almost all visits Mcat was β-lactamase
positive.
Antibiotic susceptibility of middle ear fluid isolates
compared to NP isolates at healthy visits
Oxacillin resistance of Spn in the MEF from AOM visits
was not significantly different from Spn isolates at
healthy visits. 42 (27.6%) of 152 Spn isolates from MEF
at AOM visits were oxacillin resistant compared to 187
(28.5%) of 656 Spn isolates from NP at healthy visits.
Comparison of Spn with MIC of ≥2 μg/ml to penicillin
in MEF isolates and NP isolates at healthy visits showed
17.5% of 103 MEF isolates of Spn were penicillin-
resistant compared to 6.7% of 509 NP isolates at healthy
visits, which was significantly different (p = 0.001). 73
(37.2%) of 196 NTHi isolates from MEF at onset of AOM
were β-lactamase positive compared to 57 (22.5%) of the
253 NTHi NP isolates during healthy visits (p = 0.001).
Antibiotic susceptibility of middle ear fluid isolates
compared to NP isolates at onset of AOM
42 (27.6%) of 152 Spn isolates from MEF were oxacillin
resistant. 98 (38.3%) of 256 isolates of Spn from the NP
at onset of AOM were oxacillin resistant, significantly
lower comparing MEF isolates with NP cultures at on-
set of AOM (p < 0.001). Comparison of Spn with MIC
of ≥2 μg/ml to penicillin in MEF and NP isolates showed
17.5% of 103 MEF isolates of Spn were penicillin-resistant
Table 2 Distribution of otopathogens from children with AOM where same otopathogens were observed in the NP and
MEF site (N = 165)
Correlation of MEF otopathogens with their NP site
Otopathogens Number Percentage calculated with exact match
of otopathogens with MEF total (n = 165)
Percentage calculated with
total AOM cases (n = 530)
S. pneumoniae 37 22.4 6.98
Nontypeable H. influenzae 61 37.0 11.5
M. catarrhalis 29 17.6 5.5
NTHi + S. pneumoniae 9 5.5 1.7
M. catarrhalis + S. pneumoniae 19 11.5 3.6
NTHi +M. catarrhalis 4 2.4 0.8
NTHi +M. catarrhalis + S. pneumoniae 1 0.6 0.2
Other bacteria 5 3.0 0.9
Note: In 354 (68.2%) AOM cases the MEF etiology didn’t match exactly with the NP site of the children.
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compared to 12.7% of NP isolates at onset of AOM, which
was not significantly different (p = 0.612). 73 (37.2%) of
196 NTHi were β-lactamase positive. The proportion of
β-lactamase positive in NTHi MEF cultures was not sig-
nificantly different from NP cultures collected at onset of
AOM (p = 0.287). To calculate whether antibiotic resist-
ance of MEF pathogens can be predicted from NP isolates
obtained at onset of AOM, we compared oxacillin resist-
ance in 127 paired NP and MEF Spn isolates and found
the PPV to be very high at 95.3%. Similarly comparison of
β-lactamase activity of 170 paired isolates of NTHi showed
the predictive value at 96%.
Discussion
Historically during the early 1970s to early 1990s, the
relative proportion of otopathogens in MEF during
AOM was 40% for S. pneumoniae, 25% for H. influenzae
and 12% for M. cattarrhalis [20]. After the introduction
of PCV-7 vaccine in the early 2000’s, changes in the fre-
quency and distribution of AOM pathogens occurred
[15,17,21,22]. We sought to determine if NP cultures
could be used to predict MEF cultures in the post PCV
era. In this study from June 2006-August 2013, the rela-
tive proportion of otopathogens in MEF during AOM
was 28.7% Spn, 37% NTHi and 19.6% Mcat. Thus our
group and others have shown the introduction of PCV-7
and more recently PCV-13 has reduced the contribution
of Spn causing AOM [15,17,22-24].
Can NP samples taken during healthy visits serve as a
surrogate for MEF cultures? The results from the
present study show that predicting the etiology of AOM
in MEF cultures by analyzing NP cultures at healthy
visits is poor and cannot be recommended as a substi-
tute strategy for collection of MEF.
Are NP cultures taken at onset of AOM concordant
with MEF cultures? NP cultures collected at onset of
AOM to predict MEF culture results are somewhat bet-
ter than NP cultures collected at healthy visits. The PPV
for NP cultures at onset of AOM compared to MEF was
48.8% for Spn, 70.6% for NTHi and 36.9% for Mcat.
NPV values for all the pathogens were high.
Can antibiotic susceptibility of otopathogens collected
from the MEF be predicted by otopathogen isolates ob-
tained from the NP at healthy or at onset of AOM visits?
Our data show poor correlation in predicting the antibiotic
resistance of microorganisms in the MEF compared to NP
samples taken during healthy visits. In comparison we
found antibiotic susceptibility of otopathogens collected




Prevalence (NW/MEF) PPV NVP Sensitivity Specificity
+/+ +/- -/+ -/- 95% Confidence intervals
S. pneumoniae 127 133 19 251 48.85 92.96 86.99 65.36
4.62 to 55.1 89.23 to 95.71 80.42 to 91.98 60.37 to 70.12
NTHi 170 83 17 260 67.19 93.86 90.91 75.80
61.03 to 72.94 90.35 to 96.38 85.84 to 94.61 70.91 to 80.24
M. catarrhalis 93 159 10 268 36.9 96.4 90.29 62.76
30.93 to 43.19 93.48 to 98.26 82.87 to 95.24 57.99 to 67.36
Note: PPV: Positive predictive value. NPV: Negative predictive value.
Figure 1 Distribution of S. pneumoniae, NTHi and M. catarrhalis bacteria at 6, 9, 12, 15, 18 and 24 months of age during healthy
colonization and their presence in MEF during AOM. The healthy colonization of each bacteria increased significantly with age but no significant
difference was observed with age during AOM. A negative trend with age was observed for S. pneumoniae in MEF during AOM shown by dotted line
in the figure.
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from the MEF can be predicted by otopathogen isolates
obtained from the NP at onset of AOM visits.
We postulated and found that the correlation of NP
otopathogens isolated at healthy visits occurring within
one month before AOM would be stronger than cul-
tures taken at times further distant from onset of
AOM. The results are consistent with prior work show-
ing that typical pathogenesis of AOM involves recent
(generally < 2 weeks) acquisition of a potential oto-
pathogen progressing to cause the infection [25,26].
We observed that Spn and NTHi NP colonization in-
creased significantly between 6 and 30-36 months of
age, but as children got older the relationship between
detection of a potential otopathogen in the NP with de-
tection in MEF got weaker. Our results are in agreement
with Syrjanen et al [27] who also found a high preva-
lence of NP colonization but low frequency of Spn as an
etiology of AOM with age, especially after children be-
came >18 months of age. However, neither our results
nor those of Syrjanen et al [27] allow confidence to use
NP cultures as surrogates of MEF cultures in children
below 2 years of age. Our results are consistent and also
support a Finnish study by Kilpi et al [28] where they
showed that the incidence of Spn AOM peaked at
12 months of age, whereas the incidence of NTHi AOM
peaked later at 20 months of age.
Our study has potential limitations. Our results were
obtained from a single community and mostly from a
single private pediatric practice. However, we have com-
pared our MEF culture results in the past to those of
Bardstown KT [29,30], Pittsburgh PA [31] and Fairfax
VA [32,33] where tympanocentesis has been performed
and found results to be similar [22]. Also, while partici-
pating in multicenter trials of new antimicrobial agents
and pneumococcal conjugate vaccines during the 1990s
and 2000s, our center had MEF culture results similar to
multiple other U.S. centers but not to centers outside
the U.S. where tympanocentesis was performed [34-37].
Conclusions
In conclusion, the overall results bring into question the
epidemiologic value of NP cultures to predict otopatho-
gen mix or anticipated antibiotic susceptibility patterns
among otopathogens. The results published here extend
and confirm those of another recent paper from our
group [17] in showing that NP isolation of otopathogens
at onset of AOM better reflect, albeit incompletely, likely
MEF isolates compared with NP isolates at times of
health. We will continue to collect MEF at our otitis
media research center for the coming years and collect
NP cultures in order to provide results to the health care
community for review and consideration in recommen-
dations for AOM management.
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